性能参数 |
|||
产品名称 |
Docetaxel |
||
规格 |
10mM (in 1mL DMSO) 50mg 100mg |
||
货号 |
GOY-Y2063 |
||
含量 |
>98.00% |
||
CAS |
114977-28-5 |
||
别名 |
Taxotere, Docetaxel anhydrous, Trihydrate |
|
|
化学名 |
N/A |
分子式 |
C43H53NO14 |
分子量 |
分子 807.88 |
溶解度 |
≥ 40.4mg/mL in DMSO, ≥ 94.4 mg/mL in EtOH |
储存条件 |
4°C, protect from light |
General tips |
|
用途 |
仅供科研 |
价格 |
电询 |
|
|||
详细内容 |
Docetaxel is an antineoplastic drug by inhibiting microtubule depolymerization, and attenuating of the effects of bcl-2 and bcl-xL gene expression. Docetaxel (DOC) and Glufosfamide (GLU) single and combined treatments affect the cells viability in a dose-dependent manner. The IC50 of GLU are 70±4 μM and 86.8±8 μM in PC-3 and LNCaP cells; respectively. While, the IC50 of Docetaxel alone is found to be 3.08±0.4 nM and 1.46±0.2 nM in PC-3 and LNCaP cells; respectively. The co-treatment of GLU with Docetaxel is found to synergize the cytotoxicity and the IC50 values are decreased to be 2.7±0.1 nM and 0.75±0.3 nM in PC-3 and LNCaP cells; respectively[1]. IC50 of NCI-H460 to Docetaxel at 24 h is 116 nM and at 72 h is 30 nM. According to data reported in DTP Data Search, the mean IC50 of NCI-60 cell panel to Docetaxel is 14-34 nM[2]. In female mice, the Docetaxel-induced intestinal apoptosis in the 14-hours after light on (HALO) group is significantly greater than that in the 2-HALO group. Bax expression is significantly elevated by Docetaxel in the 2-HALO group, but not in the 14-HALO group. On the other hand, cleaved Caspase-3 expression is significantly elevated by Docetaxel in the 14-HALO group, but not in the 2-HALO group. The expressions of Wee1 and phosphorylated CKD1 are significantly elevated after dosing of Docetaxel at 14 HALO, but not at 2 HALO. In addition, Docetaxel significantly reduces survivin expression in the 14-HALO group but not in the 2-HALO group. The survivin expression level in the Docetaxel-treated 14-HALO group is significantly smaller than that in the drug-treated 2-HALO group[3]. Piperine (PIP) is administrated via intravenous bolus at 3.5 mg/kg and via oral administration at 35 mg/kg and 3.5 mg/kg, while Docetaxel (DOX) is intravenously administrated at 7 mg/kg to Sprague-Daley rats. The co-administrations of PIP at 35 mg/kg via oral administration and Docetaxel at 7 mg/kg via intravenous bolus administration in Sprague-Dawley rats. The combination use of PIP and Docetaxel results in a synergic increase of both their in vivo exposure[4]. References: [1]. Attia RT, et al. The chemomodulatory effects of glufosfamide on docetaxel cytotoxicity in prostate cancer cells. PeerJ. 2016 Jun 29;4:e2168. [2]. Che CL, et al. DNA microarray reveals different pathways responding to paclitaxel and docetaxel in non-small cell lung cancer cell line. Int J Clin Exp Pathol. 2013 Jul 15;6(8):1538-48. [3]. Obi-Ioka Y, et al. Involvement of Wee1 in the circadian rhythm dependent intestinal damage induced by docetaxel. J Pharmacol Exp Ther. 2013 Oct;347(1):242-8. [4]. Li C, et al. Non-linear pharmacokinetics of piperine and its herb-drug interactions with docetaxel in Sprague-Dawley rats. J Pharm Biomed Anal. 2016 Sep 5;128:286-93. |
公司正在销售的产品:
3-(**基硅基炔基)噻吩 97% 罗丹明B AR 三乙基硅烷三氟甲烷磺酸酯 98% 癸二酸 色谱固定液,155℃ N-[(**基硅)甲基]苄胺 98% 无水碳酸钾钠 AR 2-(**硅基)乙醇 98% 司班60 色谱固定液 三(**硅基)硅烷 90% 硫标准溶液 轻质矿物油中硫标准品,100ng/ml 3-(**基硅烷基)炔丙基溴 97% 硫标准溶液 1000ug/ml,基体:1%HCl |
LB4270810mM (in 1mL DMSO) 5mg 10mg>98.00%Cas No. 226929-39-1C30H27BrN4O2 Lapatinib Ditosylate10mM (in 1mL DMSO) 50mg 100mg>98.00%Cas No. 388082-78-8C29H26ClFN4O4S 2C7H8O3S Lapatinib10mM (in 1mL DMSO) 50mg 100mg>98.00%Cas No. 231277-92-2C29H26ClFN4O4S L7919431mg 5mg 10mg>98.00%Cas No. 192767-01-4C24H17F10NO4 L-Iduronic Acid (sodium salt)1mg 5mg 10mg>98.00%Cas No. 61199-83-5C6H9O7.Na LJ5701mg 5mg 25mg>98.00%Cas No. 2252488-69-8C??H??O? Lithocholic Acid 3-sulfate (sodium salt)5mg 10mg 25mg>98.00%Cas No. 64936-81-8C24H38O6S ? 2Na |
传真号码:021-39596320 021-39921927
QQ: 3004918891 3004905818 3004901493
移动电话:18321818584 15026555973
地址:上海松江新砖公路1155号
产品均为实验试剂,仅供科研实验使用,非药品、非食品、不可用于动物及人体!